|Sponsored|February 14, 2022

World's First 0% THC, High CBD Hemp Cultivar Enters U.S. Market

Colorado hemp seed genetics company Trilogene Seeds is introducing the world's first hemp cultivar engineered to prevent THC production.

The patent pending "THC Null" trait was developed by a team of university professors and bio-engineering experts over a two-and-a-half-year period using RNA interference (RNAi) technology to silence the genetic pathways that produce THC in a hemp plant.

THC Null cultivars are not physiologically different from any other hemp. They simply cannot make THC — the psychoactive compound found in the cannabis plant, including marijuana, and in minimal amounts, hemp.

The introduction of THC-free hemp genetics means the global hemp industry can finally move forward without fear of running afoul of THC-limiting laws, said Matt Haddad, CEO of Trilogene Seeds.

Hemp farmers risk losing their crop and the threat of criminal charges if their hemp produces more THC than legally allowed. In the U.S, hemp farmers are subjected to a strict .3% limit on THC. By comparison, marijuana typically contains 20% or more THC.

"This varietal will also dramatically improve extraction efficiencies to optimize for CBD without THC limitations," Haddad said. In 2020, nearly 9% of the 70,530 hemp acres planted in the U.S. went hot, according to New Frontier Data.

"Hemp has been under the iron fist of unreasonable government regulations and farmers have risked everything with hemp crops that went hot due to no fault of their own," Haddad said. "Trilogene Seeds' THC Null trait is the result of applying cutting-edge technological tools to address the key issue stifling the growth of the hemp industry."

The THC Null trait also makes CBD hemp production more efficient. In unaltered hemp plants, CBD increases in step with THC. Therefore, hemp cultivars could only produce relatively low amounts of CBD or other non-psychoactive cannabinoids or terpenes before they breached THC thresholds.

Now, however, growers and processors will be able to work with much less hemp biomass to produce the same amount of CBD isolate, Haddad said.

Trilogene's first THC Null cultivar, "Pandora," has a 17 to 22 percent CBD profile and will be available as a "clone-only" varietal this spring in the U.S. market. Seeds for the U.S. and international markets will be available this fall.

For more information, email Trilogene at [email protected].


Related to this article

2025 Medical Cannabis Roundup
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Image | adobe.stock/Stock Rocket
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
Manipulating Cannabis Genetics: Pulling Levers to Increase  Phytochemical Composition
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
Image | adobe.stock/Maksim Kabakou
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!